NeuroPace Inc
Data quality: 100%
NPCE
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
$14.26
▼
$0.39
(-2.66%)
Mkt Cap: 480.09 M
Price
$14.26
Mkt Cap
480.09 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Revenue grew 21.97% annually over 5 years — strong growth
Debt/Equity of 3.17 — high leverage
Negative free cash flow of -11.34 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.16%
Capital efficient — spends only 0.33% of revenue on capex
Growth
Revenue Growth (5Y)
21.97%
Above sector avg (1.92%)
Revenue (1Y)25.13%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-113.10%
Below sector avg (-54.47%)
ROIC-14.62%
Net Margin-21.47%
Op. Margin-16.34%
Safety
Debt / Equity
3.17
Above sector avg (0.30)
Current Ratio4.86
Interest Coverage-2.19
Valuation
PE (TTM|NTM)
-22.37 | -40.36
Below sector avg (-1.49)
P/B Ratio25.93
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1385 peers)
Peer Comparison
vs Manufacturing sector median (1385 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -22.4 | -1.5 |
| P/B | 25.9 | 1.6 |
| ROE % | -113.1 | -54.5 |
| Net Margin % | -21.5 | -41.5 |
| Rev Growth 5Y % | 22.0 | 1.9 |
| D/E | 3.2 | 0.3 |
Analyst Price Target
8 analysts
Buy
Current
$14.26
Target
$19.88
$18.00
$20.00
$22.00
Forecast
Forward P/E
-40.36
Forward EPS
-$0.35
Est. Revenue
123.08 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
-$0.35
-$0.68 – -$0.06
|
123.08 M | 6 |
| FY2026 |
-$0.60
-$0.79 – -$0.38
|
98.91 M | 7 |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 |
-$0.20
-$0.24 – -$0.12
|
23.17 M | 7 |
| 2026 Q1 |
-$0.22
-$0.29 – -$0.18
|
21.65 M | 7 |
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q42025 | -$0.15 | -$0.08 | +48.1% |
| Q32025 | -$0.19 | -$0.11 | +43.6% |
| Q22025 | -$0.22 | -$0.26 | -19.8% |
| Q12025 | -$0.24 | -$0.21 | +10.7% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25.13% | Revenue Growth (3Y) | 23.63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 21.97% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 99.99 M | Net Income (TTM) | -21.47 M |
| ROE | -113.10% | ROA | -20.12% |
| Gross Margin | 77.23% | Operating Margin | -16.34% |
| Net Margin | -21.47% | Free Cash Flow (TTM) | -11.34 M |
| ROIC | -14.62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 3.17 | Current Ratio | 4.86 |
| Interest Coverage | -2.19 | Asset Turnover | 0.94 |
| Working Capital | 75.72 M | Tangible Book Value | 18.52 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -22.37 | Forward P/E | -40.36 |
| P/B Ratio | 25.93 | P/S Ratio | 4.80 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 3.90 | Fwd Earnings Yield | N/A |
| FCF Yield | -2.36% | ||
| Market Cap | 480.09 M | Enterprise Value | 518.19 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.66 | Revenue / Share | 2.97 |
| FCF / Share | -0.34 | OCF / Share | -0.33 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.33% | FCF Conversion | 52.82% |
| SBC-Adj. FCF | -22.41 M | Growth Momentum | 3.16 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 99.99 M | 79.91 M | 65.42 M | 45.52 M | 45.18 M |
| Net Income | -21.47 M | -27.14 M | -32.96 M | -47.08 M | -36.08 M |
| EPS (Diluted) | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 |
| Gross Profit | 77.22 M | 59.09 M | 48.12 M | 32.49 M | 33.44 M |
| Operating Income | -16.34 M | -21.67 M | -27.17 M | -40.79 M | -23.74 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 27.89 M | 23.65 M | 20.78 M | 21.95 M | 18.21 M |
| SG&A Expenses | — | 57.10 M | 54.52 M | 51.34 M | 38.96 M |
| D&A | — | — | — | — | — |
| Interest Expense | 7.46 M | 8.80 M | 8.52 M | 7.53 M | 7.41 M |
| Income Tax | 0.0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 105.57 M | 94.65 M | 107.65 M | 114.11 M | 133.56 M |
| Total Liabilities | 86.53 M | 86.63 M | 87.00 M | 79.33 M | 60.06 M |
| Shareholders' Equity | 19.03 M | 8.01 M | 20.65 M | 34.78 M | 73.50 M |
| Total Debt | 58.88 M | 59.53 M | 56.95 M | 52.91 M | 49.85 M |
| Cash & Equivalents | 21.69 M | 13.43 M | 18.06 M | 6.61 M | 19.19 M |
| Current Assets | 94.07 M | 81.34 M | 92.72 M | 97.71 M | 132.82 M |
| Current Liabilities | 17.81 M | 15.16 M | 16.23 M | 10.98 M | 9.30 M |
{"event":"ticker_viewed","properties":{"ticker":"NPCE","listing_kind":"stock","pathname":"/stocks/npce","exchange":"NASDAQ","country":"US"}}